PEP vs PTGX · P/E 22, rev $43.62B vs rev $269.8M
PepsiCo Inc (PEP) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Luis Laguarta.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
PEP currently screens at market cap $193.55B and trailing P/E 22.2. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the PEP and PTGX stock pages for the full models.
Not investment advice.